Diffusion of medical technology: The role of financing
Diffusion of medical technology: The role of financing
复制标题
DOI：
10.1016/j.healthpol.2010.10.004
复制
发表时间：
2011-04-01
期刊：
影响因子：
3.3
通讯作者：
Anessi-Pessina, Eugenio
中科院分区：
文献类型：
--
作者：
Cappellaro, Giulia;Ghislandi, Simone;Anessi-Pessina, Eugenio
在过去的十年中，医疗技术创新的步伐加快了：因此，需要更好地识别和理解在临床实践中采用和传播医疗技术创新背后的真实的力量。在这些力量中，财政激励可能会发挥主要作用。本文的目的是评估新的医疗设备和相关程序的融资机制对其扩散的影响。该分析在意大利住院心血管领域进行，并应用于2003年至2007年期间的药物洗脱支架。该论文的主要假设，即较高的报销水平鼓励技术扩散，被拒绝。私立医院可能比公立医院对关税水平更敏感的假设也是如此。一个统计学上的显着差异，发现只有在诊断相关组（DRGs）的基础上资助的医院和那些没有，前者显示出更高水平的技术diffusion.These结果警告政策制定者对过度依赖特定的报销费用的变化，作为一种方式来指导供应商的行为。(C)2010爱思唯尔爱尔兰有限公司版权所有。
In the last decade the pace of innovation in medical technology has accelerated: hence the need to better identify and understand the real forces behind the adoption and diffusion of medical technology innovations in clinical practice.Among these forces, financial incentives may be expected to play a major role. The purpose of this paper was to assess the influence of financing mechanisms for new medical devices and correlated procedures on their diffusion. The analysis was carried out in the Italian inpatient cardiovascular area and applied to drug eluting stents over the period 2003-07.The paper's main hypothesis, that higher levels of reimbursement encourage technology diffusion, was rejected. So was the hypothesis that private hospitals may be more sensitive to tariff levels than public hospitals. A statistically significant difference was found only between hospitals that are funded on a Diagnosis-Related Groups (DRGs) basis and those that are not, with the former showing higher levels of technology diffusion.These results warn policy makers against excessive reliance on specific reimbursement fee changes as a way of steering provider behaviour. (C) 2010 Elsevier Ireland Ltd. All rights reserved.